Table 1. Summary of associations between 11 SNPs in miR-101 and breast cancer risk.

SNP	Chr	Position	Location	Allelesa	Caseb	Controlb	Call rate	MAFc	HWEd	OR(95% CI)e	P valuee
					N = 1064	N = 1073	(%)	(case/control)
rs7536540	1p31.3	65,524,582	hsa-mir-101-1	G/C	338/528/197	351/510/211	97.94	0.434/0.435	0.291	0.998(0.881–1.131)	0.982
rs1011210	1p31.3	65,526,176	hsa-mir-101-1	A/G	405/516/133	442/466/159	97.19	0.371/0.367	0.048	–	–
rs555146	1p31.3	65,527,407	hsa-mir-101-1	C/A	838/205/20	832/218/23	97.94	0.115/0.123	0.064	0.930(0.772–1.121)	0.446
rs578481	1p31.3	65,528,755	hsa-mir-101-1	A/G	507/460/97	535/436/101	97.99	0.307/0.298	0.381	1.042(0.910–1.192)	0.552
rs705509	1p31.3	65,531,751	hsa-mir-101-1	G/A	326/512/216	339/510/220	97.33	0.448/0.444	0.293	1.034(0.914–1.171)	0.594
rs462480	9p24.1	4,850,436	hsa-mir-101-2	A/C	531/442/88	591/395/86	97.80	0.291/0.265	0.084	1.182(1.030–1.357)	0.017
rs17718377	9p24.1	4,854,472	hsa-mir-101-2	G/C	821/227/13	845/218/10	97.85	0.119/0.111	0.437	1.113(0.914–1.356)	0.287
rs4742051	9p24.1	4,858,997	hsa-mir-101-2	A/G	576/412/74	618/386/68	97.85	0.264/0.244	0.456	1.139(0.988–1.314)	0.074
rs1537146	9p24.1	4,859,303	hsa-mir-101-2	A/G	623/388/51	655/361/57	97.89	0.231/0.222	0.426	1.081(0.931–1.255)	0.308
rs10974820	9p24.1	4,859,872	hsa-mir-101-2	G/A	875/180/8	905/162/5	97.89	0.092/0.080	0.538	1.174(0.938–1.469)	0.162
rs1053872	9p24.1	4,860,643	hsa-mir-101-2	C/G	265/532/265	305/541/226	97.85	0.500/0.463	0.667	1.179(1.040–1.337)	0.010

^aMajor/minor allele;

^bMajor homozygote/heterozygote/rare homozygote between cases and controls;

^cMinor allele frequency (MAF);

^d P values for Hardy-Weiberger equilibrium (HWE) tests;

^eLogistic regression with adjustment for age, age at menarche and menopausal status in additive model.